zur Navigation zum Inhalt
Hämatologie 9. Oktober 2013

What’s new in Hodgkin’s lymphoma: ASH 2012 and more

Modern treatment strategies have resulted in an excellent overall survival in the majority of patients with Hodgkin’s lymphoma. PET-stratification is used to guide treatment in patients with limited disease in clinical trials, but recent results indicate that combined treatment with chemotherapy and radiotherapy is still the standard of care. Prediction of treatment related mortality and new data about chemotherapy induced infertility will guide our decisions especially in patients with advanced disease and brentuximab vedotin is now an approved option in patients with relapsed or refractory disease.

Thomas Melchardt, Lukas Weiss, Richard Greil, Priv. Doz. Alexander Egle, memo - Magazine of European Medical Oncology 3/2013

Volltext dieses Beitrags / entire article auf SpringerLink

Zu diesem Thema wurden noch keine Kommentare abgegeben.

Mehr zum Thema

<< Seite 1 >>

Medizin heute

Aktuelle Printausgaben